TRIM21 and nasopharyngeal carcinoma: To explore whether TRIM21 impairs antitumour immunity in NPC in vivo, we generated NPC xenografts with TRIM21-KO or -WT SUNE1 cells in humanised NOD/SCID/IL2rγ null mice (Supplementary Fig. 7e, f).